SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000 | -37.5% | 3,842 | +6.9% | 0.00% | – |
| Q2 2023 | $24,000 | – | 3,594 | +71780.0% | 0.00% | – |
| Q1 2023 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 5 | -99.6% | 0.00% | – |
| Q1 2022 | $4,000 | -85.7% | 1,260 | -69.4% | 0.00% | – |
| Q4 2021 | $28,000 | +21.7% | 4,121 | +76.1% | 0.00% | – |
| Q3 2021 | $23,000 | -25.8% | 2,340 | +135.6% | 0.00% | – |
| Q2 2021 | $31,000 | -39.2% | 993 | -14.2% | 0.00% | – |
| Q1 2021 | $51,000 | – | 1,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |